AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · Massachusetts

H4986

Relative to therapeutic psilocybin treatment centers

Status

Pending

2026 Session

IntroducedJan 28, 2026 (done)
PassedNext step (current)
Signed— (upcoming)
Law in effect— (upcoming)

Sponsor: Joint Committee on Public Health (Committee)
Type: Therapeutic Access
Substances: Psilocybin

Official text

Summary (from PoliPsy)

Relative to therapeutic psilocybin treatment centers

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: malegislature.gov

Legislative history

July 9, 2026
Reporting date extended to Thursday, December 31, 2026
January 28, 2026
Referred
January 28, 2026
Introduced

Loading bill…